Dr. Ashkar was invited to speak at Cambridge Healthtech Institute’s NK Cell-Based Cancer Immunotherapy Symposium in Boston, to share the lab's work on autologous ex vivo expanded NK cells for solid tumor immunotherapy.
top of page
Search
Recent Posts
See AllThe Ashkar lab received a $100,000 research grant from the Juravinski Hospital and Cancer Centre Foundation to develop autologous NK cell...
bottom of page
Comments